1. Home
  2. MCB vs ABUS Comparison

MCB vs ABUS Comparison

Compare MCB & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$78.92

Market Cap

957.3M

Sector

Finance

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.26

Market Cap

884.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
ABUS
Founded
1999
2005
Country
United States
United States
Employees
328
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
957.3M
884.7M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
MCB
ABUS
Price
$78.92
$4.26
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$97.50
$5.00
AVG Volume (30 Days)
175.1K
2.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.02%
N/A
EPS Growth
11.64
13.64
EPS
6.62
N/A
Revenue
$11,053,000.00
$6,171,000.00
Revenue This Year
$33.38
$125.30
Revenue Next Year
$9.32
N/A
P/E Ratio
$11.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.08
$2.71
52 Week High
$97.84
$5.10

Technical Indicators

Market Signals
Indicator
MCB
ABUS
Relative Strength Index (RSI) 33.90 43.48
Support Level $73.21 $4.23
Resistance Level $80.94 $4.69
Average True Range (ATR) 3.20 0.23
MACD -1.09 -0.03
Stochastic Oscillator 14.80 6.25

Price Performance

Historical Comparison
MCB
ABUS

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: